Ansun Biopharma, Inc.
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| DAS181 for STOP COVID-19 (NCT04354389) | Ansun Biopharma, Inc. | 2020-07-25 |
| DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) (NCT04298060) | Ansun Biopharma, Inc. | 2020-07-01 |
| Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study (NCT03808922) | Ansun Biopharma, Inc. | 2019-05-23 |
Track Ansun Biopharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.